APO RESEARCH · REPORT
1-Butyl-2-Methylimidazole
1-Butyl-2-Methylimidazole is a heterocyclic chemical substance identified by its named ring and substituent structure.

Product & engineering
Understand the product.
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1-Butyl-2-Methylimidazole. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
The commercial boundary
Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.
Which supplied interfaces and acceptance criteria define 1-Butyl-2-Methylimidazole?
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1-Butyl-2-Methylimidazole. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
Selected research
Market Structure
Global 1-Butyl-2-Methylimidazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global 1-Butyl-2-Methylimidazole market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for 1-Butyl-2-Methylimidazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for 1-Butyl-2-Methylimidazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for 1-Butyl-2-Methylimidazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for 1-Butyl-2-Methylimidazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of 1-Butyl-2-Methylimidazole include Manus Aktteva Biopharma LLP, Jiangxi Jinkai Chemical Co.,Ltd and IoLiTec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines 1-Butyl-2-Methylimidazole output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of 1-Butyl-2-Methylimidazole by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global 1-Butyl-2-Methylimidazole market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of 1-Butyl-2-Methylimidazole and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents 1-Butyl-2-Methylimidazole sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 1-Butyl-2-Methylimidazole market size, projected growth trends, production technologies, key applications, and end-use industries.
1-Butyl-2-Methylimidazole Segment by Company
Manus Aktteva Biopharma LLP
Jiangxi Jinkai Chemical Co.,Ltd
IoLiTec
1-Butyl-2-Methylimidazole Segment by Type
Above 98%
Others
1-Butyl-2-Methylimidazole Segment by Application
Chemical Intermediate
Others
1-Butyl-2-Methylimidazole Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 1-Butyl-2-Methylimidazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 1-Butyl-2-Methylimidazole and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 1-Butyl-2-Methylimidazole.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the 1-Butyl-2-Methylimidazole market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 1-Butyl-2-Methylimidazole industry.
Chapter 3: Detailed analysis of 1-Butyl-2-Methylimidazole market competition landscape. Including 1-Butyl-2-Methylimidazole manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of 1-Butyl-2-Methylimidazole by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of 1-Butyl-2-Methylimidazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Above 98%
- Others
Applications
- Chemical Intermediate
- Others
Companies covered
- Manus Aktteva Biopharma LLP
- Jiangxi Jinkai Chemical Co.,Ltd
- IoLiTec
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global 1-Butyl-2-Methylimidazole Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global 1-Butyl-2-Methylimidazole Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global 1-Butyl-2-Methylimidazole Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global 1-Butyl-2-Methylimidazole Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global 1-Butyl-2-Methylimidazole Market Dynamics
- 2.1 1-Butyl-2-Methylimidazole Industry Trends
- 2.2 1-Butyl-2-Methylimidazole Industry Drivers
- 2.3 1-Butyl-2-Methylimidazole Industry Opportunities and Challenges
- 2.4 1-Butyl-2-Methylimidazole Industry Restraints
3 1-Butyl-2-Methylimidazole Market by Manufacturers
- 3.1 Global 1-Butyl-2-Methylimidazole Production Value by Manufacturers (2021-2026)
- 3.2 Global 1-Butyl-2-Methylimidazole Production by Manufacturers (2021-2026)
- 3.3 Global 1-Butyl-2-Methylimidazole Average Price by Manufacturers (2021-2026)
- 3.4 Global 1-Butyl-2-Methylimidazole Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 1-Butyl-2-Methylimidazole Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global 1-Butyl-2-Methylimidazole Manufacturers, Product Type & Application
- 3.7 Global 1-Butyl-2-Methylimidazole Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global 1-Butyl-2-Methylimidazole Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 1-Butyl-2-Methylimidazole Players Market Share by Production Value in 2025
- 3.8.3 2025 1-Butyl-2-Methylimidazole Tier 1, Tier 2, and Tier 3
4 1-Butyl-2-Methylimidazole Market by Type
- 4.1 1-Butyl-2-Methylimidazole Type Introduction
- 4.1.1 Above 98%
- 4.1.2 Others
- 4.2 Global 1-Butyl-2-Methylimidazole Production by Type
- 4.2.1 Global 1-Butyl-2-Methylimidazole Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global 1-Butyl-2-Methylimidazole Production by Type (2021-2032)
- 4.2.3 Global 1-Butyl-2-Methylimidazole Production Market Share by Type (2021-2032)
- 4.3 Global 1-Butyl-2-Methylimidazole Production Value by Type
- 4.3.1 Global 1-Butyl-2-Methylimidazole Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global 1-Butyl-2-Methylimidazole Production Value by Type (2021-2032)
- 4.3.3 Global 1-Butyl-2-Methylimidazole Production Value Market Share by Type (2021-2032)
5 1-Butyl-2-Methylimidazole Market by Application
- 5.1 1-Butyl-2-Methylimidazole Application Introduction
- 5.1.1 Chemical Intermediate
- 5.1.2 Others
- 5.2 Global 1-Butyl-2-Methylimidazole Production by Application
- 5.2.1 Global 1-Butyl-2-Methylimidazole Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global 1-Butyl-2-Methylimidazole Production by Application (2021-2032)
- 5.2.3 Global 1-Butyl-2-Methylimidazole Production Market Share by Application (2021-2032)
- 5.3 Global 1-Butyl-2-Methylimidazole Production Value by Application
- 5.3.1 Global 1-Butyl-2-Methylimidazole Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global 1-Butyl-2-Methylimidazole Production Value by Application (2021-2032)
- 5.3.3 Global 1-Butyl-2-Methylimidazole Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Manus Aktteva Biopharma LLP
- 6.1.1 Manus Aktteva Biopharma LLP Company Information
- 6.1.2 Manus Aktteva Biopharma LLP Business Overview
- 6.1.3 Manus Aktteva Biopharma LLP 1-Butyl-2-Methylimidazole Production, Value and Gross Margin (2021-2026)
- 6.1.4 Manus Aktteva Biopharma LLP 1-Butyl-2-Methylimidazole Product Portfolio
- 6.1.5 Manus Aktteva Biopharma LLP Recent Developments
- 6.2 Jiangxi Jinkai Chemical Co.,Ltd
- 6.2.1 Jiangxi Jinkai Chemical Co.,Ltd Company Information
- 6.2.2 Jiangxi Jinkai Chemical Co.,Ltd Business Overview
- 6.2.3 Jiangxi Jinkai Chemical Co.,Ltd 1-Butyl-2-Methylimidazole Production, Value and Gross Margin (2021-2026)
- 6.2.4 Jiangxi Jinkai Chemical Co.,Ltd 1-Butyl-2-Methylimidazole Product Portfolio
- 6.2.5 Jiangxi Jinkai Chemical Co.,Ltd Recent Developments
- 6.3 IoLiTec
- 6.3.1 IoLiTec Company Information
- 6.3.2 IoLiTec Business Overview
- 6.3.3 IoLiTec 1-Butyl-2-Methylimidazole Production, Value and Gross Margin (2021-2026)
- 6.3.4 IoLiTec 1-Butyl-2-Methylimidazole Product Portfolio
- 6.3.5 IoLiTec Recent Developments
7 Global 1-Butyl-2-Methylimidazole Production by Region
- 7.1 Global 1-Butyl-2-Methylimidazole Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global 1-Butyl-2-Methylimidazole Production by Region (2021-2032)
- 7.2.1 Global 1-Butyl-2-Methylimidazole Production by Region (2021-2026)
- 7.2.2 Global 1-Butyl-2-Methylimidazole Production Forecast by Region (2027-2032)
- 7.3 Global 1-Butyl-2-Methylimidazole Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global 1-Butyl-2-Methylimidazole Production Value by Region (2021-2032)
- 7.4.1 Global 1-Butyl-2-Methylimidazole Production Value by Region (2021-2026)
- 7.4.2 Global 1-Butyl-2-Methylimidazole Production Value by Region (2027-2032)
- 7.5 Global 1-Butyl-2-Methylimidazole Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America 1-Butyl-2-Methylimidazole Production Value (2021-2032)
- 7.6.2 Europe 1-Butyl-2-Methylimidazole Production Value (2021-2032)
- 7.6.3 Asia-Pacific 1-Butyl-2-Methylimidazole Production Value (2021-2032)
- 7.6.4 South America 1-Butyl-2-Methylimidazole Production Value (2021-2032)
- 7.6.5 Middle East & Africa 1-Butyl-2-Methylimidazole Production Value (2021-2032)
8 Global 1-Butyl-2-Methylimidazole Consumption by Region
- 8.1 Global 1-Butyl-2-Methylimidazole Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global 1-Butyl-2-Methylimidazole Consumption by Region (2021-2032)
- 8.2.1 Global 1-Butyl-2-Methylimidazole Consumption by Region (2021-2026)
- 8.2.2 Global 1-Butyl-2-Methylimidazole Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America 1-Butyl-2-Methylimidazole Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America 1-Butyl-2-Methylimidazole Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe 1-Butyl-2-Methylimidazole Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe 1-Butyl-2-Methylimidazole Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific 1-Butyl-2-Methylimidazole Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific 1-Butyl-2-Methylimidazole Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America 1-Butyl-2-Methylimidazole Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America 1-Butyl-2-Methylimidazole Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa 1-Butyl-2-Methylimidazole Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa 1-Butyl-2-Methylimidazole Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 1-Butyl-2-Methylimidazole Value Chain Analysis
- 9.1.1 1-Butyl-2-Methylimidazole Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 1-Butyl-2-Methylimidazole Production Mode & Process
- 9.2 1-Butyl-2-Methylimidazole Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 1-Butyl-2-Methylimidazole Distributors
- 9.2.3 1-Butyl-2-Methylimidazole Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst